University of Colorado Eye Center
Welcome,         Profile    Billing    Logout  
 5 Trials 
4 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Oliver, Scott C
PROTECT-V, NCT04870333 / 2020-004144-28: PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V

Recruiting
2/3
5000
Europe
Niclosamide, Placebo, Ciclesonide, Sotrovimab
Cambridge University Hospitals NHS Foundation Trust, Life Arc, Kidney Research UK (KRUK), UNION therapeutics, Addenbrookes Charitable Trust, GlaxoSmithKline, National Institute for Health Research, United Kingdom
Covid19
07/24
12/24
Seibold, Leonard K
VENICE, NCT05280366: STREAMLINE®SURGICAL SYSTEM Compared to iStent Inject W® in Patients With Open-Angle Glaucoma

Active, not recruiting
N/A
150
US, RoW
Streamline Surgical System, iStent Inject W
New World Medical, Inc.
Open Angle Glaucoma
06/26
06/26
Preston, Mary
NCT05002998: TEPEZZA® (Teprotumumab-trbw) Post-Marketing Requirement Study

Active, not recruiting
4
313
Europe, US
Teprotumumab, TEPEZZA, Placebo, Saline Solution
Amgen
Thyroid Eye Disease
04/26
04/26
NCT04417530: Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma

Completed
2
22
US
AU-011, Suprachoroidal Microinjector, PDT Laser
Aura Biosciences
Uveal Melanoma, Ocular Melanoma, Choroidal Melanoma
04/24
04/24

Download Options